Titlebook: Microvascular Decompression Surgery; Shi-Ting Li,Jun Zhong,Raymond F. Sekula, Jr. Book 20161st edition Springer Science+Business Media Dor

古生物學(xué)

書目名稱Microvascular Decompression Surgery影響因子(影響力)




書目名稱Microvascular Decompression Surgery影響因子(影響力)學(xué)科排名




書目名稱Microvascular Decompression Surgery網(wǎng)絡(luò)公開度




書目名稱Microvascular Decompression Surgery網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Microvascular Decompression Surgery被引頻次




書目名稱Microvascular Decompression Surgery被引頻次學(xué)科排名




書目名稱Microvascular Decompression Surgery年度引用




書目名稱Microvascular Decompression Surgery年度引用學(xué)科排名




書目名稱Microvascular Decompression Surgery讀者反饋




書目名稱Microvascular Decompression Surgery讀者反饋學(xué)科排名

glamor

https://doi.org/10.1007/978-94-017-7366-9Glossopharyngeal Neuralgia; Hemifacial spasm; Microvascular decompression; Neurogenic hypertension; Trig

Immunotherapy

978-94-024-1336-6Springer Science+Business Media Dordrecht 2016

TRACE

Shi-Ting Li,Jun Zhong,Raymond F. Sekula, Jr.Provides MVD surgery in separate chapters in hemifacial spasm, trigeminal neuralgia, glossopharyngeal neuralgia.Introduces this surgery as an effective remedy for cranial nerve hyperexcitability disor

使堅硬

Petter Jannatta MD, PhDcts of taking back are known as ...This introduction sketches the main debates in which retraction has been appealed to, signals the issues the authors think are interesting and worth pursuing, and describes what the contributions to this volume—gathering together for the first time work from the se

和藹

Ken Matsushima MD,Xiaochun Jiang MD,Albert L. Rhoton Jr. MD completion of the first graft rejection, suggesting that memory T cells had been produced following the first transplant. However the mechanisms of memory induction and the phenotypic and functional differences between memory and effector T cells remain controversial. The allograft response entails

繁榮地區(qū)

Aage R. M?ller PhD, DMedScited by recurrence of hematological malignancy. Additional immune suppression is usually necessary before retransplantation, and patients are usually very sensitive to the toxicity of additional conditioning therapy, especially if the time interval after initial transplantation is short. The feasibil

不可思議

Insufficient

Andrew M. Frederickson BS, MS,Michael S. Gold PhD,Raymond F. Sekula Jr. MD, MBA, FACSted by recurrence of hematological malignancy. Additional immune suppression is usually necessary before retransplantation, and patients are usually very sensitive to the toxicity of additional conditioning therapy, especially if the time interval after initial transplantation is short. The feasibil

FUSC